08:35 AM EDT, 05/06/2024 (MT Newswires) -- Krystal Biotech ( KRYS ) reported Q1 earnings Monday of $0.03 per diluted share, swinging from a net loss of $1.76 a year earlier.

Analysts polled by Capital IQ expected $0.15.

Net product revenue for the quarter ended March 31 was $45.3 million. The biotech company did not report revenue last year. Analysts surveyed by Capital IQ expected $47.4 million.

The company said it ended the quarter with $622.3 million in cash, cash equivalents, and investments.

Shares of Krystal Biotech ( KRYS ) were down more than 17% in recent Monday premarket activity.

Price: 133.00, Change: -28.10, Percent Change: -17.44